BioSpace News Archive

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

CMAB Biopharma Inc., a dedicated biologics contract manufacturing and development organization, announced the appointment of Mr. Ye Shi as the Head of Quality.

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, updated its first-quarter 2020 guidance and provided a business update in light of the global COVID-19 crisis.

$200,000 donation helps fight global health crisis and enhance local care

Premier medical & scientific cannabis conference to contribute 10% of ticket sales to support CDC Emergency Response Fund to help mitigate the public health threat

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), today announced the closing of its previously announced registered direct offering of 1,713,064 shares of common stock, at a purchase price of $2.335 per share, for gross proceeds of approximately $4.0 million priced at-the-market under Nasdaq rules

Sorrento Therapeutics, Inc. announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies derived from the postpartum human placenta.

While on quarantine, now is the perfect time for proven quit smoking online and phone support from the American Lung Association

Newly created GBT Community Fund to provide $150,000 in grants to U.S. non-profits addressing the needs of the sickle cell disease community

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, announced a new initiative that galvanizes its transatlantic network of academic institutions, foundations, and philanthropic partners to accelerate promising, near-term therapies to treat COVID-19 and its complications and battle future pandemic threats.